2004
DOI: 10.1007/bf02254375
|View full text |Cite
|
Sign up to set email alerts
|

Abi enhances Abl-mediated Cdc2 phosphorylation and inactivation

Abstract: Abelson tyrosine kinase (Abl) is a non-receptor tyrosine kinase which is frequently coupled with adaptor proteins to interact with its substrates for the regulation of cytoskeleton rearrangement, cell growth and apoptosis in response to a variety of biological stimuli. The Abl interactor (Abi) family members were first identified as adaptor proteins of Abl for regulating Abl transforming and kinase activity. In the present study, we used a yeast two-hybrid screen to identify Cdc2 as a novel Abi-binding protein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 25 publications
1
17
0
Order By: Relevance
“…Supporting this model, one very recent study has 3105 RESEARCH ARTICLE Abi suppresses Abl in Drosophila demonstrated that Abl can inhibit the role of Abi in the engulfment of apoptotic cells in C. elegans (Hurwitz et al, 2009). Given that Abi is the Abl kinase substrate and that it also functions as an adaptor protein for Abl in regulating other downstream effectors (Juang and Hoffmann, 1999;Tani et al, 2003;Lin et al, 2004;Leng et al, 2005;Maruoka et al, 2005) Since our data suggest an antagonistic interaction between abi and Abl for the CNS and NMJ phenotypes (Fig. 2), we speculated that Abl heterozygosity would suppress the semilethal phenotype of abi mutants.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…Supporting this model, one very recent study has 3105 RESEARCH ARTICLE Abi suppresses Abl in Drosophila demonstrated that Abl can inhibit the role of Abi in the engulfment of apoptotic cells in C. elegans (Hurwitz et al, 2009). Given that Abi is the Abl kinase substrate and that it also functions as an adaptor protein for Abl in regulating other downstream effectors (Juang and Hoffmann, 1999;Tani et al, 2003;Lin et al, 2004;Leng et al, 2005;Maruoka et al, 2005) Since our data suggest an antagonistic interaction between abi and Abl for the CNS and NMJ phenotypes (Fig. 2), we speculated that Abl heterozygosity would suppress the semilethal phenotype of abi mutants.…”
Section: Discussionmentioning
confidence: 95%
“…Abi was first identified as an Abl kinase substrate, functioning in modulating the transformation activity of oncogenic Abl in human cancers (Dai and Pendergast, 1995;Shi et al, 1995;Wang et al, 2007;Yu et al, 2008). Intriguingly, we and others have shown that Abi also functions as an activator of Abl kinase activity (Juang and Hoffmann, 1999;Tani et al, 2003;Lin et al, 2004;Leng et al, 2005;Maruoka et al, 2005). Moreover, the interaction of Abl and Abi can trigger an array of biochemical and functional changes in Abi, including protein phosphorylation, stability and subcellular localization (Huang et al, 2007), which might ultimately lead to the control of a particular biological process in vivo.…”
Section: Discussionmentioning
confidence: 98%
“…In the present study, we identified Abi2 as a protein that binds to TRIM32, suggesting a novel mechanism of TRIM32 in carcinogenesis in human head and neck squamous cell carcinoma. We focused on Abi2 among candidates detected by yeast-two hybrid screening because it has been reported that Abi2 suppresses cell growth (23) and that a truncated form accelerates the tumorigenesis (22). Theses previous reports suggest that Abi2 functions as a tumor suppressor.…”
Section: Discussionmentioning
confidence: 99%
“…Abi2 promotes Abl-mediated phosphorylation of Cdc2 and inactivation of Cdc2 kinase activity, leading to suppression of cell growth (23). Coexpression of a truncated form of Abi2 with c-Abl activates the oncogenic potential of c-Abl, suggesting that the full-length Abi2 functions as a tumor suppressor (22).…”
Section: Introductionmentioning
confidence: 99%
“…Cell lysate was produced in lysis buffer or extract buffer 38 for Cdk5 immunoprecipitation. Proteins were analyzed by direct Western blotting (30 mg/lane) or blotting after immunoprecipitation (1-2 mg/immunoprecipitation).…”
Section: Methodsmentioning
confidence: 99%